Leqselvi (Deuruxolitinib

Leqselvi (deuruxolitinib), a Janus kinase (JAK) inhibitor, is approved for treating adults with severe alopecia areata, a condition characterized by significant hair loss. It works by targeting specific pathways in the immune system to reduce inflammation and promote hair regrowth.

Limitations of Use: It is important to note that deuruxolitinib should not be used in combination with other JAK inhibitors, biologic immunomodulators, cyclosporine, or other powerful immunosuppressants, as these combinations can lead to unwanted side effects.

Recommended Dosage: The recommended dosage of Deuruxolitinib for treating severe alopecia areata is 8 mg taken orally twice daily, with or without food. If a dose is missed, it is advised to skip the missed dose and continue with the next scheduled dose. 

• Patients taking deuruxolitinib 8 mg tablets may face an increased risk of serious infections such as bacterial, viral, or fungal infections. Regular monitoring and immediate medical attention are essential. Avoid using this medicine in individuals with active or chronic infections.
  
• Treatment with deuruxolitinib has been associated with an elevated risk of mortality, particularly in older patients or those with pre-existing cardiovascular conditions. Careful assessment of risk factors and patient history is advised before prescribing this treatment.
  
• Patients treated with this therapeutic drug may have a higher risk of developing malignancies and lymphoproliferative disorders. Regular monitoring and periodic assessments for malignancy should be considered throughout the treatment period, especially in high-risk individuals.
  
• Treatment with Leqselvi (deuruxolitinib tablets) is linked to an increased risk of Major Adverse Cardiovascular Events (MACE), including heart attack and stroke. Patients with cardiovascular risk factors should be carefully monitored, and immediate action should be taken if symptoms arise.
  
• Leqselvi 8 mg capsules use may elevate the risk of thrombosis, including deep vein thrombosis (DVT) and pulmonary embolism (PE). Ensure proper patient evaluation and monitoring for signs of blood clots during the treatment process to mitigate risks.
  
• Patients taking deuruxolitinib oral tablets may face a rare but serious risk of gastrointestinal perforations. Early detection and intervention are critical. Physicians should monitor for nausea, abdominal pain, or changes in bowel movements to prevent complications.
  
• This medicinal product is not recommended during pregnancy or breastfeeding due to potential harm to the fetus or infant. Women of childbearing potential should use effective contraception during therapy and consult their physician about risks before use.
  

What documents are required to import LEQSELVI to India?

LEQSELVI (deuruxolitinib) tablets can be imported by patients or government hospitals on the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
  
• Patients diagnostic reports
  
• Patient ID proof (issued by the government of India)

How does the order be confirmed?

• The order will be confirmed only after the receipt of:
  
• A valid prescription from the Doctor
  
• Import permit if applicable

Is LEQSELVI available in India?

LEQSELVI (deuruxolitinib tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Leqselvi in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
  
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
  
• Medicine Price.
  
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
  
• Ensuring 100% transparency.
  

LEQSELVI can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of LEQSELVI (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Leqselvi 8 mg tablets price in India. 

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source the LEQSELVI (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Leqselvi®?

Deuruxolitinib is a Generic Name for the trade name drug Leqselvi®.

What is the Manufacturer’s Name of Leqselvi®?

Leqselvi® is manufactured by Sun Pharmaceutical Industries, Inc.

Is Leqselvi® approved by the FDA?

Yes, Leqselvi® is approved by the FDA. Date of first approval: July 25, 2024.

What is the dosage and form of Leqselvi® supplied?

Leqselvi® is supplied in Tablets of 8 mg for oral administration.

What are the most common side effects of Leqselvi®? 

The most common side effects of Leqselvi® are acne, headache, nasopharyngitis, neutropenia, blood creatine phosphokinase increased, hyperlipidemia, fatigue, lymphopenia, thrombocytosis, anemia, skin and soft tissue infections, weight increased, and herpes.

How much does Leqselvi® 8 mg cost in India?

Prices may fluctuate over time due to market dynamics and regulatory changes. To obtain accurate and up-to-date information on Leqselvi 8 mg tablets cost in India, it is recommended that you Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Leqselvi® be available in SAARC countries? 

Apart from Gulf countries, Leqselvi® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the supply of Leqselvi® tablets in these countries, ensuring access to this therapeutic drug through legal and reliable channels.

Is it safe to buy Leqselvi® 8 mg tablets online in India?

Yes, one can buy Leqselvi 8 mg online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Leqselvi® tablets through legal channels. 

What are the storage conditions of Leqselvi® 8 mg tablets?

Leqselvi® 8 mg tablets should be stored at room temperature, below 30°C, in a dry place, away from moisture and heat.